Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
drugs
4
×
fda
4
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
4
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
cancer
eli lilly
abbvie
astrazeneca
bristol-myers squibb
cancer immunotherapy
investing
medical device
merck
nonalcoholic steatohepatitis
What
drug
4
×
fda
approved
bio
companies
new
roundup
alzheimer’s
annual
approval
arguments
assessed
attention
big
biotech
cancer
class
commercialized
communities
competitors
conference
decades
deeper
digital
disease
dna
drugs
epidemic
esmo
europe
fatty
fingerprint
frenzied
genetic
germany
going
growing
hosted
investment
known
Language
Current search:
fda
×
drug
×
drugs
×
" seattle top stories "
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More